Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perseghin, G.
Right arrow Articles by Luzi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perseghin, G.
Right arrow Articles by Luzi, L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:2207-2211, 2002
© 2002 by the American Diabetes Association, Inc.


Epidemiology/Health Services/Psychosocial Research
Original Article

Fasting Blood Sample-Based Assessment of Insulin Sensitivity in Kidney-Pancreas-Transplanted Patients

Gianluca Perseghin, MD1, Andrea Caumo, MD1, Lucia Piceni Sereni, MD1, Alberto Battezzati, MD1,2 and Livio Luzi, MD1

1 Nutrition/Metabolism, Istituto Scientifico H San Raffaele, Milan, Italy
2 International Center for the Assessment of Nutritional Status, Università degli Studi di Milano, Milan, Italy

OBJECTIVE—To ascertain whether simple indexes of insulin sensitivity based on a fasting blood sample may be reliable measures of insulin sensitivity in combined kidney-pancreas- transplanted patients.

RESEARCH DESIGN AND METHODS—Estimates of insulin sensitivity based on fasting plasma glucose, insulin (homeostasis model assessment of insulin sensitivity [HOMA-IS], Quantitative Insulin Sensitivity Check Index [QUICKI]), and free fatty acid (revised QUICKI) concentrations were compared with insulin sensitivity as assessed with the gold standard technique (euglycemic-hyperinsulinemic clamp) in 22 patients who had undergone kidney-pancreas transplantation (KP-Tx) and 18 matched healthy subjects (NOR).

RESULTS—In KP-Tx patients, indexes based on the glucose-insulin product, HOMA-IS (r = 0.47, P = 0.03) and QUICKI (r = 0.47, P = 0.03), were shown to be reliable measures of insulin sensitivity. The introduction of fasting plasma free fatty acid concentration in the revised QUICKI (r = 0.76, P < 0.0001) considerably improved the power of prediction of the clamp-based measure of insulin sensitivity as observed in the healthy control subjects (r = 0.83, P < 0.0001).

CONCLUSIONS—This study shows that in KP-Tx patients, HOMA-IS and QUICKI are reliable measures of insulin sensitivity; the additional incorporation of fasting plasma free fatty acid concentration into the glucose-insulin product (revised QUICKI) resulted in a considerably more powerful index.

Abbreviations: CV, coefficient of variation • FFA, free fatty acid • GIR, glucose infusion rate • KP-Tx, kidney-pancreas transplantation • HOMA-IS, homeostasis model assessment of insulin sensitivity • HOMA-IR, homeostasis model assessment of insulin resistance • NOR, matched healthy subjects • QUICKI, Quantitative Insulin Sensitivity Check Index


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
P. Fiorina, A. Vergani, A. Petrelli, F. D'Addio, L. Monti, R. Abdi, E. Bosi, P. Maffi, and A. Secchi
Metabolic and Immunological Features of the Failing Islet-Transplanted Patient
Diabetes Care, March 1, 2008; 31(3): 436 - 438.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Stadler, C. Anderwald, T. Karer, A. Tura, T. Kastenbauer, M. Auinger, C. Bieglmayer, O. Wagner, F. Kronenberg, P. Nowotny, et al.
Increased Plasma Amylin in Type 1 Diabetic Patients After Kidney and Pancreas Transplantation: A sign of impaired {beta}-cell function?
Diabetes Care, May 1, 2006; 29(5): 1031 - 1038.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.